A052020 Share Price Performance
₩7,280.00
1120.00 (18.18%)
Price ₩7,280.00
Share Price₩7,280.00
Companies Like STCube (KOSDAQ:052020) Are In A Position To Invest In Growth
Sep 23
STCube, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A052020 Community Narratives
There are no narratives available yet.
Recent A052020 News & Updates
STCube, Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -312.23
- Gross Margin
- 9.15%
- Net Profit Margin
- -249.16%
- Debt/Equity Ratio
- 0%
STCube, Inc. Competitors
Snowflake Analysis
About A052020
- Founded
- 1989
- Employees
- 13
- CEO
- WebsiteView website
STCube, Inc., a biopharmaceutical company, develops medicines in South Korea. The company develops anti-cancer immunotherapeutic drugs and anti-viral drugs. It offers platform technologies, which include In vivo RNAi ICP target discovery platform for exploring material ICP target; glycosylation-specific antibody development platform for development of antibodies that mask glycosylation sites on target proteins; and ICP functional assay platform for development of various in vivo/in vitro analytical/experimental methods. The company’s product pipeline consists of various anti-cancer drugs, including anti PD-L1 Ab and anti PD-1 Ab in preclinical study, and anti STT-005 for solid tumor; anti STT-003 Ab in phase-1 for lung, head, and neck cancer; small molecule STT-011 inhibitor candidate development for pancreatic cancer; anti STT-012 Ab for breast and prostate cancer; and anti STT-013 Ab for solid tumor. The company was formerly known as Schem Co., Ltd. and changed its name to STCube, Inc. in April 2008. The company was founded in 1989 and is headquartered in Seoul, South Korea.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
South Korean Market Performance
- 7 Days: 1.0%
- 3 Months: 11.4%
- 1 Year: 33.4%
- Year to Date: 46.1%
The market is up 1.0% over the last week, with the Information Technology sector leading the way, up 4.5%. The market is up 33% over the last 12 months. As for the next few years, earnings are expected to grow by 25% per annum. Market details ›